15 results · 23ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

ILUMIEN, Drageonfly OPTIS Imaging Catheter

FDA 510(k)
FDA Class 2 ·Radiology

HHM

FDA UDI
Oticon A/S·05707131286123·H160V2 TI, RITE 312 WL DBL HHM

APEX Revision Knee

FDA UDI
Omni Life Science, Inc.·00841690122760·Modular Stem 23mm x 75mm

DIALYSATE METER, MODEL D-6

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

STARSHIELD V3 RF TRNT

FDA 510(k)
FDA Class 2 ·Radiology

T:SLIM X2 INSULIN PUMP WITH INTEROPERABLE TECHNOLOGY

FDA Adverse Event
Malfunction ·TANDEM DIABETES CARE·Product code QFG·May 28, 2020

RADIFOCUS OPTITORQUE

FDA Adverse Event
Malfunction ·TERUMO CORPORATION, ASHITAKA·Product code DQX·June 13, 2022

ONETOUCHPING GLUCOSEMGMTSYSTEM

FDA Adverse Event
Malfunction ·ANIMAS CORPORATION·Product code LZG·June 6, 2013

ADVANTAGE SERIES 26

FDA Adverse Event
Malfunction ·STRYKER MEDICAL·Product code FPO·June 10, 2011

SPDLNK 5.5 TRANS CNTR MED 43-51MM

FDA Adverse Event
Injury ·ABBOTT SPINE·Product code KWP·September 3, 2008

OPTITORQUE ANGIOGRAPHIC CATHETER

FDA Adverse Event
Malfunction ·Product code DQO·January 20, 2021

BD VACUTAINER® SST¿ BLOOD COLLECTION TUBES

FDA Adverse Event
Malfunction ·BECTON DICKINSON IND. CIRURGICAS LTDA·Product code JKA·March 13, 2025

Remel Blood Agar/MacConkey Agar Bi-Plate, REF: R02049

FDA Enforcement
Class II ·Terminated·Remel Inc·January 20, 2021

EDI BZO UNCUT SHEET-CARD, Item No. 100170 These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

FDA Enforcement
Class II ·Terminated·Ameditech Inc·November 25, 2015

SIGMA Spectrum Infusion Pump, Model/Catalog Number: 35700BAX2

FDA Enforcement
Class II ·Ongoing·Baxter Healthcare Corporation·January 28, 2026